Insmed, Inc. (INSM): Price and Financial Metrics


Insmed, Inc. (INSM)

Today's Latest Price: $38.32 USD

3.93 (-9.30%)

Updated Jan 27 4:00pm

Add INSM to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 488 in Biotech

See all "A" rated Strong Buy stocks

INSM Stock Summary

  • With a price/sales ratio of 25.51, INSMED Inc has a higher such ratio than 90.9% of stocks in our set.
  • Revenue growth over the past 12 months for INSMED Inc comes in at 67.71%, a number that bests 92.27% of the US stocks we're tracking.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for INSM comes in at -6.13% -- higher than that of 26.57% of stocks in our set.
  • Stocks that are quantitatively similar to INSM, based on their financial statements, market capitalization, and price volatility, are NSTG, WISA, CYRN, JG, and HLIT.
  • INSM's SEC filings can be seen here. And to visit INSMED Inc's official web site, go to www.insmed.com.

INSM Stock Price Chart Interactive Chart >

Price chart for INSM

INSM Price/Volume Stats

Current price $38.32 52-week high $44.37
Prev. close $42.25 52-week low $12.09
Day low $37.50 Volume 1,208,384
Day high $41.41 Avg. volume 914,100
50-day MA $37.81 Dividend yield N/A
200-day MA $30.86 Market Cap 3.90B

Insmed, Inc. (INSM) Company Bio


Insmed Incorporated is a biopharmaceutical company focused on developing targeted inhaled therapies for patients suffering from rare lung diseases. The company was founded in 1999 and is based in Bridgewater, New Jersey.


INSM Latest News Stream


Event/Time News Detail
Loading, please wait...

INSM Latest Social Stream


Loading social stream, please wait...

View Full INSM Social Stream

Latest INSM News From Around the Web

Below are the latest news stories about INSMED Inc that investors may wish to consider to help them evaluate INSM as an investment opportunity.

Is OSI Systems, Inc.'s(NASDAQ:OSIS) Recent Stock Performance Tethered To Its Strong Fundamentals?

Most readers would already be aware that OSI Systems' (NASDAQ:OSIS) stock increased significantly by 14% over the past...

Yahoo | January 22, 2021

Insmed (INSM) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by Insmed Incorporated in conjunction with this event....

SA Transcripts on Seeking Alpha | January 19, 2021

Insmed "Unbreakable" by ROOF Studio

The team at ROOF Studio in New York engage their talents for hyper-detailed worlds and characters to elevate this film designed to raise awareness of NTM Lung Disease for biopharmaceutical brand Insmed thru agency AREA 23.

Stash | January 14, 2021

Insmed to Present at the 39th Annual J.P. Morgan Healthcare Conference

BRIDGEWATER, N.J., Jan. 5, 2021 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the virtual 39th Annual J.P. Morgan…

PR Newswire | January 5, 2021

Insmed initiates frontline trial program for Arikayce in MAC lung disease

Insmed ([[INSM]] -0.2%) announced that first patient was dosed in late December, 2020, in the frontline clinical trial program of Arikayce (amikacin liposome inhalation suspension) in patients with nontuberculous mycobacterial ((NTM)) lung disease caused by Mycobacterium avium complex ((MAC)).The program consists of ARISE, an interventional study designed to validate cross-sectional and longitudinal characteristics...

Seeking Alpha | January 4, 2021

Read More 'INSM' Stories Here

INSM Price Returns

1-mo 12.38%
3-mo 21.00%
6-mo 46.71%
1-year 85.03%
3-year 38.04%
5-year 190.30%
YTD 15.11%
2020 39.41%
2019 82.01%
2018 -57.92%
2017 135.68%
2016 -27.11%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9263 seconds.